Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives

Details for Australian Patent Application No. 2008206575 (hide)

Owner Savvipharm Inc.

Inventors Karmali, Rashida A.

Agent Cullen & Co

Pub. Number AU-A-2008206575

PCT Pub. Number WO2008/088909

Priority 11/655,801 18.01.07 US

Filing date 18 January 2008

Wipo publication date 24 July 2008

International Classifications

A61K 31/525 (2006.01)

C07D 475/12 (2006.01) Heterocyclic compounds containing pteridine ring systems

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/088909 Priority application(s): WO2008/088909

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206582-Controlling the position of an agricultural implement coupled to an agricultural vehicle based upon three-dimensional topography data

2008206570-Systems and methods for analyzing information technology systems using collaborative intelligence